GSK Pharma. Result Update. Buy

Size: px
Start display at page:

Download "GSK Pharma. Result Update. Buy"

Transcription

1 Result Update GSK Pharma Buy Margins continue to hold above 21% The company continues to improve their margins. Company reported overall flat revenue with EBITDA margins at 2% taking the PAT growth to 7%. Revenue is deflated by an estimated 5% during the quarter, that is predominately profit neutral, and arisi88ng from the impact of the implemented GST rates. Adjusting for GST, high single to double digit volume growth on key brands and therapy areas is observed by the management. During the quarter, the company has received the money in advance towards disposal of Thane land. Q3FY18 Financial Highlights Revenues was flat YoY to ` 7.bn. EBITDA jumped 172% YoY to ` 1.4bn, taking margin to 2.1% (vs 7.4% last year). Sequentially the product mix has hurt the gross margins which we believe largely seasonal in nature. Reported PAT witnessed a growth of 69% YoY to ` 897mn (adjusting for theexceptional income in base PAT grew by 111%). Capex Plans The ongoing capacity expansion at Vemgal is underway with a planned capex of ` 1bn. This facility is being built on a 5-acre plot and supposed to manufacture 8bn tablets and 1bn capsules. In addition to the site infrastructure the facility will include a warehouse, employee welfare center other utilities to support manufacturing and packaging activities. This capex is expected to lay down the base for sustainable growth in the coming years. Company looks at spending nearly ` 5.bn on capex in FY18E. Outlook and Valuation We maintain our positive outlook on the stock. Company has successfully managed to address vaccines shortages and other supply constrains from parent group last year. It re-launched Neosporin and two new launches in FY17 (mostly in last quarter) which is expected to reflect better revenue traction in FY18E. However, given GST implementation fiasco these efforts may not fully be visible this fiscal. Company is yet to launch three more respiratory products and one diabetic drug along with two more vaccines from its parent s pipeline over coming two years. The ongoing capacity expansion at Vemgal and Nashik is expected to get more earnings traction from FY19E onwards. We have a BUY rating on the stock with a rolled over target price of ` 3,1. We would recommend adding to the positions on every decline. At CMP of ` 2,439, the stock is trading at 46x FY19E EPS of ` 53 and 38x FY2E EPS of ` 64. Q3FY18 Result (` Mn) Particulars Q3FY18 Q3FY17 YoY Q2FY18 QoQ Net Sales 7,39 7,64 (.3) 8,363 (15.5) Operating profit 1, ,921 (72.9) EBITDA 1, ,921 (72.9) Other Income (19.1) Depreciation (14.5) PBT 1, ,94 (68.9) Tax (63.4) Exceptional item PAT ,33 (59.4) (bps) (bps) Operating margin , (282) EBITDA margins , (282) Tax Rate (572) NPM (284) February 2, 218 CMP ` 2,439 Target / Upside ` 3,1/27% BSE Sensex 35,67 NSE Nifty 1,761 Scrip Details Equity / FV Market Cap ` 847mn / `1/- ` 27bn USD 3.2bn 52-week High/Low ` 2,795/2,39 Avg. Volume (no) 15,615 NSE Symbol Bloomberg Code Shareholding Pattern Dec 17 GLAXO GLXO IN Promoters 75. MF/Banks/FIs 1.7 FIIs 2.1 Public / Others 12.2 Valuation (x) FY18E FY19E FY2E P/E EV/EBITDA ROE ROCE Estimates (` mn) FY18E FY19E FY2E Net Sales 3,143 33,76 39,837 EBITDA 5,661 7,81 8,949 PAT 3,951 4,515 5,45 EPS Sr. Analyst: Cyndrella Carvalho Tel: cyndrella@dolatcapital.com Associate: Srishti Tel: srishti@dolatcapital.com

2 Dec'14 Mar'15 Jun'15 Sep'15 Dec'15 Mar'16 Jun'16 Sep'16 Dec'16 Mar'17 Jun'17 Sep'17 Dec'17 Dec'14 Mar'15 Jun'15 Sep'15 Dec'15 Mar'16 Jun'16 Sep'16 Dec'16 Mar'17 Jun'17 Sep'17 Dec'17 Revenue gaining momentum EBITDA margin at 2% in Q3FY18 1 Revenue Growth EBITDA EBITDA Margin (12).6 8 (24). Recovering PAT growth Downtrend in Interest Income as expected 1.6 PAT Growth 15 (` mn) 28 Other Income Growth (75) 7. (15) (1) February 2, 218 2

3 Income Statement (` mn) Particulars Mar17 Mar18E Mar19E Mar2E Net Sales 29,265 3,143 33,76 39,837 Growth Total Expenditure 25,571 24,84 27,71 31,331 Raw material consumed 5,237 6,24 6,752 7,569 Purchase of finished goods 7,97 7,87 7,765 9,83 Decrease/(Increase) in stocks 834 (766) 1 13 Employee benefit expenses 4,83 4,521 5,42 6,294 Selling & Distribution expenses 2,465 2,864 2,87 3,386 Administrative expenses 2,937 3,44 2,695 3,113 Other operating expenses 1,361 1,13 1,587 1,872 Operating profit 3,455 5,514 6,925 8,785 Other operating income EBIDTA (Excl. Other Income) 4,19 5,661 7,81 8,949 EBIDTA (Incl. Other Income) 4,918 6,236 7,529 9,148 Other Income Depreciation Exceptional Items (457) Profit Before Tax 5,112 5,941 6,758 8,159 Tax 1,744 1,99 2,244 2,79 Net Profit 3,368 3,951 4,515 5,45 Adj Net Profit 2,911 3,951 4,515 5,45 Growth (22) Balance Sheet (` mn) Particulars Mar17 Mar18E Mar19E Mar2E Sources of Funds Equity Capital Reserves 19,222 2,123 2,573 21,958 Net Worth 2,69 2,97 21,42 22,85 Secured Loans Unsecured Loans 6 Loan Funds Total Capital Employed 2,85 2,98 21,43 22,815 Applications of Funds Net Block 2,527 11,87 14,315 16,216 Capital Work in Progress 6,55 4, 4, 4, Non-current Investments Long-term loans and advances ,113 1,92 Other non-current assets 4,478 4,65 4,35 3,91 Cash & current investment 9,321 7,89 5,688 6,518 Other current assets 7,421 6,135 6,379 6,872 sub total 21,381 18,176 17,215 18,384 Less: Current Liabilities & Provisions Current Liabilities 6,723 6,988 7,613 8,731 Provisions 3,21 5,349 6,541 7,17 sub total 9,933 12,337 14,154 15,838 Total Assets 2,85 2,98 21,43 22,815 E Estimates Cash Flow (` mn) Particulars Mar17 Mar18E Mar19E Mar2E Profit before tax 5,112 5,942 6,759 8,16 Depreciation Change in working capital 1,673 2,455 1,179 1,211 Total tax paid (1,624) (1,571) (2,244) (2,29) Others (728) (576) (449) (199) Cash flow from oper. (a) 4,696 6,545 6,17 7,952 Capital expenditure (4,127) (6,8) (4,) (2,889) Change in investments 6 Others (11) (167) Cash flow from inv. (b) (4,132) (6,23) (3,521) (3,56) Free cash flow (a+b) ,495 4,896 Equity raised/(repaid) Debt raised/(repaid) (8) (6) Dividend (incl. tax) (3,61) (2,541) (3,896) (4,66) Others (2,93) () () Cash flow from fin. (c) (5,162) (2,547) (3,896) (4,66) Net chg in cash (a+b+c) (4,598) (2,233) (1,41) 83 Important Ratios Particulars Mar17 Mar18E Mar19E Mar2E (A) Measures of Performance EBIDTA Margin (excl. O.I.) Interest / Sales.... Tax/PBT Net Profit Margin (B) As Percentage of Net Sales Raw material consumed Purchase of finished goods Dec./(Increase) in stocks 2.8 (2.5).. Employee benefit expenses Selling & Distribution Exp Administrative expenses Other operating expenses (C) Measures of Financial Status Debt / Equity (x).... Interest Coverage (x).... Average Cost Of Debt.... (D) Measures of Investment EPS (`.) CEPS (`.) DPS (`.) Dividend Payout Profit Ploughback Book Value (`.) RoANW RoACE (E) Valuation Ratios CMP (`.) 2,439 2,439 2,439 2,439 P/E (x) Market Cap. (`. Mn.) 26,612 26,612 26,612 26,612 MCap/ Sales (x) EV (`. Mn.) 197,36 199,533 2,934 2,14 EV/Sales (x) EV/EBDITA (x) P/BV (x) FCFE Yield Dividend Yield E Estimate February 2, 218 3

4 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 DART RATING MATRIX Total Return Expectation (12 Months) Buy > 2% Accumulate 1 to 2% Reduce to 1% Sell < % Rating and Target Price History Month Rating TP (`) Price (`)* Oct 16 Buy 3,5 2,9 May 17 Buy 3,5 2,46 Jul 17 Buy 3,5 2,51 Oct 17 Buy 3,5 2,425 * As on Recommendation Date 2 GSK Pharma Target DART Team Purvag Shah Managing Director purvag@dolatcapital.com Amit Khurana, CFA Head of Equities amit@dolatcapital.com CONTACT DETAILS Equity Sales Designation Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com Kapil Yadav VP - Equity Sales kapil@dolatcapital.com Yomika Agarwal VP - FII Sales yomika@dolatcapital.com Derivatives Strategist Designation Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com Equity Trading Designation P. Sridhar VP and Head of Sales Trading sridhar@dolatcapital.com Chandrakant Ware AVP - Equity Sales Trading chandrakant@dolatcapital.com Derivatives Trading Designation Shirish Thakkar AVP - Derivatives shirisht@dolatcapital.com Hardik Mehta Sales Trader hardikm@dolatcapital.com Dolat Capital Market Private Limited. 2, Rajabahadur Mansion, 1st Floor, Ambalal Doshi Marg, Fort, Mumbai - 4 1

5 Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a- 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered broker-dealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U6599DD1993PTC9797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB17152 & INF17152, NSE - INB237131& INF237131, Research: INH685 Registered office: Office No. 141, Centre Point, Somnath, Daman , Daman & Diu Board: Fax: research@dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)

MRF. Result Update. Accumulate

MRF. Result Update. Accumulate Result Update MRF Accumulate Revenue disappoints MRF posted weak topline growth of 8.1% YoY at ` 38.6 bn for the quarter ended along with gross and EBITDA margins of 39.8% and 15.4% respectively. The gross

More information

Bharat Petroleum Corporation

Bharat Petroleum Corporation Result Update Bharat Petroleum Corporation Accumulate Bharat Petroleum Corporation (BPCL) s results were in-line with our estimates on revenues and below our estimates on profitability front. Revenues

More information

MRF. Result Update. Accumulate

MRF. Result Update. Accumulate Result Update MRF Accumulate Quarter marginally disappoints but outlook is intact MRF revenue grew 15.8% YoY in to ` 39bn, which was lower than our estimates of ` 4 bn. Profitability was also marginally

More information

Result Update. Sterling Tools. Buy

Result Update. Sterling Tools. Buy Sterling Tools Buy Result Update Growth momentum continues Sterling tools (STRT) number were broadly in line with estimates. Margins on a sequential basis have started showing signs of improvement at gross

More information

Techno Electric & Engineering

Techno Electric & Engineering Result Update Techno Electric & Engineering Downgrade to Reduce (Prev. Accumulate) Techno is countering the slowing T&D business by going to overseas markets for orders. It continues to manage its balance

More information

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018 Result Update Voltas Buy Softness seen in AC industry in Q4 has also got spilt over into Q1FY19, with unseasonal showers and lower temperatures playing spoilsport. The next seasonally important quarter

More information

Skipper. Result Update. Reduce

Skipper. Result Update. Reduce Result Update Skipper Reduce Muted growth; opportunities from new segments For Q4FY18, the revenue declined 3% YoY to ` 5928mn, grew 4.7% QoQ from ` 5,664mn. EBITDA grew 8% YoY to ` 185mn, grew ~47% QoQ

More information

Result Update. Atul Auto. Accumulate

Result Update. Atul Auto. Accumulate Atul Auto Accumulate Result Update Looking out for margin and distribution expansion Atul Auto (ATA) top line growth was in-line with our estimates at ` 1,765 mn but margins were lower due to higher other

More information

Result Update. Ahluwalia Contracts. Buy

Result Update. Ahluwalia Contracts. Buy Ahluwalia Contracts Buy Result Update Strong order inflow to drive growth ACIL posted 31.3% YoY growth in Q2FY19 revenue (after 2 consecutive quarter of de-growth) to `4.4 bn (9.% above estimates) led

More information

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn) Result Update Music Broadcast Buy Stable growth quarter; strong outlook for H2FY18 MBL reports revenue growth of 11.9% YoY supported by higher utilisation in new stations. EBITDA margin improved 106bps

More information

Transport Corporation of India

Transport Corporation of India Transport Corporation of India Accumulate Result Update Better numbers with improvement in industry utilisation rate Revenue up by 25.7%YoY to ` 652.5mn; grew 9% QoQ from ` 5,553.1mn. EBITDA grew by 53.6%YoY

More information

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017 Result Update HCC Accumulate Debt reduction factored in Q2FY18 standalone revenue increased by 6.5% YoY to `9.7bn (in-line with estimates) due to better execution. Excluding claims of `1.85 bn (`1.8 bn

More information

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn) Result Update Maruti Suzuki India Accumulate Growth Story Continues MSIL volume continues to remain strong at 11.3% YOY which totaled to 431,112 units during the quarter. The growth in realisations per

More information

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017 Result Update Berger Paints Downgrade to Reduce (Prev. - Accumulate) Continues to gain market share Revenues (consol.) grew by 11.% YoY to ` 12.bn in-line with our estimate. Standalone revenues were up

More information

NCC. Result Update. Accumulate

NCC. Result Update. Accumulate Result Update NCC Accumulate GST spoiled the show, but robust order inflow positive NCC posted 33.3% YoY de-growth in Q2FY18 standalone revenue to `13bn (35.8% below estimates). The fall in revenue was

More information

Simplex Infrastructures

Simplex Infrastructures Result Update Simplex Infrastructures Sell Working capital pressure continues SIL posted 7.4% YoY rise in Q1FY18 standalone revenue (increased post 6 consecutive quarters of de-growth) to `15.1bn (in line

More information

Gujarat State Petronet

Gujarat State Petronet Result Update Gujarat State Petronet Accumulate results were better than our estimates largely driven by higher than expected volumes. Higher volumes were due to low gas cost and these spot volumes resulted

More information

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018 Result Update Larsen & Toubro Accumulate Q1 was an inline quarter adjusting for IndAS changes and one-off gains. It has held on to its FY19 guidance given at the beginning of the year, making Q1 a non-event

More information

Result Update. Sterling Tools. Accumulate

Result Update. Sterling Tools. Accumulate Sterling Tools Accumulate Result Update OEM slowdown and High RM cost impacted numbers. Downgrade to Accumulate. Sterling Tools (STRT) numbers were below estimates on profitability parameters as OEM slowdown

More information

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins Result Update Maruti Suzuki India Accumulate Product mix driving margins MSIL reported volume growth of 24.3% YoY and revenue growth rate of 28% YoY in. The base was low because of multiple events such

More information

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018 Result Update INOX Leisure Accumulate Ad. growth outperformance drives profitability Inox reported healthy revenue growth YoY on back of good ad and F&B revenue. EBITDA margin improved 470bps YoY to 13.0%

More information

Result Update. Havells. Buy

Result Update. Havells. Buy Result Update Havells Buy Q2 was weak on the margin front with input cost pressures visible. The one bright spot has been the inventory build-up for the festive season in the ECD business, as evident in

More information

Shemaroo Entertainment

Shemaroo Entertainment Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Result Update India (Entertainment) Institutional Research Shemaroo Entertainment Buy CMP ` 330 Target / Upside

More information

Result Update. Tech Mahindra. Buy

Result Update. Tech Mahindra. Buy Tech Mahindra Buy Result Update View: Communication to aid profitability Company won deals worth USD 440mn in the quarter. Of these, USD 240mn was in the communication vertical and USD 200mn in enterprise.

More information

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Dilip Buildcon. Result Update. Buy. Stellar performance continues Result Update Dilip Buildcon Buy Stellar performance continues DBL s standalone revenue grew sharply by 72.6% YoY to `15.8bn in Q2FY18 (37.2% above estimates) due to better execution run rate in Road and

More information

Balkrishna Industries

Balkrishna Industries Annual Report Analysis Balkrishna Industries Accumulate Distribution expansion is the focus area Balkrishna Industries (BKT) has highlighted the importance of distribution reach and higher number of SKUs

More information

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL Result Update India (Capital Goods) Institutional Research DOLAT CAPITAL Skipper CMP ` 140 Target / Upside ` 162/16% BSE Sensex 25,400 NSE Nifty 7,783 Scrip Details Equity / FV ` 102mn/` 1/- Market Cap

More information

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL Result Update India (Capital Goods) Institutional Research DOLAT CAPITAL Skipper CMP ` 139 Target / Upside ` 145/5% BSE Sensex 26,818 NSE Nifty 8,296 Scrip Details Equity / FV ` 102mn/` 1/- Market Cap

More information

Result Update. Skipper. Sell

Result Update. Skipper. Sell Skipper Sell Result Update Muted ordering, slower execution increased cost leads to tepid growth For Q2FY19, the revenue grew 1.6% YoY to ` 5,239.6mn, grew 9.5% QoQ from ` 4787mn. EBITDA declined 43.2%

More information

Transport Corporation of India

Transport Corporation of India India (Logistics) Institutional Research Transport Corporation of India DOLAT CAPITAL Buy Q2FY16 Result Update CMP ` 283 Target / Downside ` 333 / 18% BSE Sensex 26,838 NSE Nifty 8,112 Scrip Details Equity

More information

Result Update. Khadim India. Buy

Result Update. Khadim India. Buy Khadim India Buy Result Update Delay in price hike impacted margins Khadim s revenues beat our estimates, but EBITDA and APAT came below our estimate. The revenue growth in retail business was at 7% -

More information

CONCOR. Management Meeting Update. Buy

CONCOR. Management Meeting Update. Buy CONCOR Buy Management Meeting Update All is well DFC continues to be the most important long-term trigger as apart from boosting volumes, it will aid margins. Distribution logistics will help reduce rail

More information

Infosys. Result Update. Buy

Infosys. Result Update. Buy Infosys Buy Result Update INFY raises its revenue guidance for FY19E in CC terms; Maintain BUY The USD revenue rose 2.3% QoQ (2.7 % QoQ CC terms) to USD 2,987 million, (DCMe: USD 2,965 million), due to

More information

Container Corporation of India

Container Corporation of India Oct16 Nov16 Dec16 Jan17 Feb17 Mar17 Apr17 May17 Jun17 Jul17 Aug17 Sep17 Company Update Container Corporation of India Buy Stacked for success CONCOR has all its key triggers in place. DFC continues to

More information

Kajaria Ceramics. Result Update. Buy

Kajaria Ceramics. Result Update. Buy Result Update Kajaria Ceramics Buy Cautiously Optimistic In the last one & half year Ceramic Industry faced multiple challenges, Demonetization and GST Implementation restricted volume growth. Collective

More information

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn) Result Update ICICI Bank Buy Mixed bag Q3FY18 PAT at ` 16.5bn down 32% YoY & 20% QoQ. NII mere 6% up YoY. NIMs stood stable YoY; down QoQ to 3.1%. Other income stood down 20% YoY & 39% QoQ; on the back

More information

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Annual Report Analysis Page Industries Accumulate Despite demonetisation, Page Industries witnessed revenue growth of

More information

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018 Annual Report Analysis Music Broadcast Buy MBL reported revenue growth of 9.9% YoY in FY18 to ` 2982mn which includes revenue from exchange of services of ` 196 as on 31 st March, 218 as compared to `

More information

Result Update ITC. Accumulate

Result Update ITC. Accumulate ITC Accumulate Result Update Volume growth improvement continues ITC s results came marginally ahead of our expectations. The cigarette business posted ~6% volume growth which was marginally better than

More information

Result Update. KEI Industries. Buy

Result Update. KEI Industries. Buy KEI Industries Buy Result Update Numbers beat estimates, Traction continues. Maintain Buy KEI Industries (KEI) numbers were ahead of estimates driven by strong sales in retail segment and expected growth

More information

Mahanagar Gas. Result Update. Accumulate

Mahanagar Gas. Result Update. Accumulate Result Update Mahanagar Gas Accumulate Volume Traction with Profitability Mahanagar Gas (MGL) numbers has outperformed on volume as well as profitability parameters. Volume traction was primarily driven

More information

Result Update. NIIT Technologies. Buy

Result Update. NIIT Technologies. Buy Result Update NIIT Technologies Buy Healthy revenue growth & margins to aid profitability; upgrade to Buy USD revenue (Ex Hedge Gain) grew 5.8% QoQ to USD 132mn (DCMe: USD 128mn) led by healthy organic

More information

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn) Annual Report Analysis Dixon Technologies Accumulate Annual Report 218- The IPO year Dixon Technologies came up with the IPO in FY18 and got a great response from investors with a 117x subscription. From

More information

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8, Consumer / Result Update Page Industries CMP: ` 11,760 TP: ` 12,992 Accumulate Q3FY15 - Volume growth of 15% Volume growth of 15.2% was backed by a strong growth in the Mens and Leisure wear segment at

More information

Q3FY19 Quarterly Preview IT Services

Q3FY19 Quarterly Preview IT Services Q3FY19 Quarterly Preview IT Services Head of Equities: Amit Khurana, CFA Associate: Vinesh Vala Tel: +91 22 40969745 Tel: +91 22 40969736 E-mail: amit@dolatcapital.com E-mail: vineshv@dolatcapital.com

More information

Kalpataru Power Transmission

Kalpataru Power Transmission Annual Report Analysis Kalpataru Power Transmission Accumulate Robust order book growth in FY18 FY18 saw the standalone order book grow at 38% YoY to ` 124bn (T&D- `84.3bn; Oil & Gas and Rail -`39.7bn)

More information

Result Update. HDFC Bank. Accumulate

Result Update. HDFC Bank. Accumulate HDFC Bank Accumulate Result Update Results in line, Caution on agricultural book HDFC bank reported a steady profit growth of 20% YoY aided by a NII growth of 22% YoY on stable NIMs, a robust core fees

More information

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn) Result Update Sagar Cement Buy Better than expected cost rationalization, drives operating performance SGC reported topline growth of 6.2% YoY to ` 2.74bn (2.3% lower than D est). EBITDA at ` 364Mn (-14.2%

More information

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues! Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Visit Note Dilip Buildcon Buy FY18E a bumper year! Show continues! Company and Strategy DBL with its differentiated business

More information

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn) Result Update JK Cement Buy Volume growth supports top-line JK Cement reported a revenue of ` 11.2bn (+26.8% YoY, +1.7% QoQ), 2% higher than D est. The cement dispatches during the quarter rose by 20.3%

More information

ICICI Bank. Result Update. Buy

ICICI Bank. Result Update. Buy Result Update ICICI Bank Buy Stress priced-in; Servings are on course Lull operating performance; retail broadens out PAT at ` 20.4bn (in-line with our est. ` 20.2bn) reporting soft QoQ growth and 8% YoY

More information

Result Update. Yes Bank. Buy

Result Update. Yes Bank. Buy Yes Bank Buy Result Update Returning to old glory days, Expect a strong rerating With the appointment of the new MD and CEO from outside the group, we believe the hiatus in the Yes bank s story is now

More information

Repco Home Finance REPCO IN

Repco Home Finance REPCO IN 11 August 2014 Price: `431 India Banking & Financial Services Company Update BUY Repco Home Finance REPCO IN 12m Price Target: `460 Steady quarter REPCO reported 1Q15 net profit at `248mn, up 11% YoY and

More information

Sanofi India. Company Update. Buy

Sanofi India. Company Update. Buy May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Company Update Sanofi India Buy Cardio time ahead CY17 has been an evolving year for the domestic pharma industry including

More information

KEC International. Annual Report Analysis. Accumulate

KEC International. Annual Report Analysis. Accumulate Annual Report Analysis KEC International Accumulate KEC International - Strong FY18 enabled by T&D and Rail business FY18 was a strong year despite facing challenges regarding GST implementation in 1HFY18

More information

Near-term pressure, but long-term outlook positive

Near-term pressure, but long-term outlook positive INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)

More information

Q3FY13 Q3FY12 YOY(%) Q2FY13

Q3FY13 Q3FY12 YOY(%) Q2FY13 Plastics / Result Update Supreme Industries CMP: ` 310 TP: ` 409 Buy High Points Supreme Industries Q3 FY13 results review Supreme Industries (SIL) for Q3FY13 has reported net revenues at ` 9.04bn (Dolat

More information

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015 RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap

More information

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 RESULTS REVIEW 1QFY15 13 AUG 2014 BHEL SELL INDUSTRY CAPITAL GOODS CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 Nifty 7,727 Sensex 25,881 KEY STOCK DATA Bloomberg/Reuters BHEL IN/BHEL.BO No. of Shares

More information

South Indian Bank. Result Update. Buy

South Indian Bank. Result Update. Buy Result Update South Indian Bank Buy "Formidable B/S in making Q2FY18 PAT took a major hit owing to upfront provisioning on value diminution of SRs issued by ARCs. The PAT at ` 43.2mn mounted YoY by huge

More information

TVS Motors. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Transport Corporation of India Ltd.

Transport Corporation of India Ltd. Jul/12 Aug/12 Sep/12 Oct/12 Nov/12 Dec/12 Jan/13 Feb/13 Mar/13 Apr/13 May/13 Jun/13 Jul/13 July 26, 2013 COMPANY RESULTS REPORT REVIEW Nifty: 5,908; Sensex: 19,805 CMP Target Price Rs49 Rs81 Potential

More information

Still on track. Exhibit 1: ICT is on track for FY09E

Still on track. Exhibit 1: ICT is on track for FY09E Country: India Sector: Indian Education Diviya Nagarajan Diviya.Nagarajan@jmfinancial.in Tel: (91 22) 6630 3066 Subhashini Gurumurthy Subhashini.Gurumurthy@jmfinancial.in Tel: (91 22) 6630 3069 Price:

More information

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty

More information

Britannia Industries

Britannia Industries Sustains momentum; Input cost gains peaked out November 09, 2015 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium Valuations to sustain, Accumulate May, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,18 Target Price Rs1,171 Implied

More information

Mahindra & Mahindra. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium valuations to sustain, Accumulate October 4, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,1 Target Price Rs1,9 Implied

More information

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 January 12, 212 COMPANY RESULTS REPORT REVIEW TTK Prestige Ltd. Enough steam left BUY Nifty: 4,831; Sensex: 16,38

More information

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart 4QFY216 Result Update Capital Goods May 11, 216 Inox Wind Performance Highlights Quarterly Data (Consolidated) ( ` cr) 4QFY16 4QFY15 % chg (yoy) 3QFY16 % chg (qoq) Total Income 1,829 93 96.6 941 94.2 EBITDA

More information

Transport Corporation of India Ltd.

Transport Corporation of India Ltd. Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 January 31, 2013 COMPANY RESULTS REPORT REVIEW Nifty: 6,035; Sensex: 19,895 CMP Target Price Rs71 Rs66 Potential

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277

More information

ITC Ltd. RESULT UPDATE 27th October, 2017

ITC Ltd. RESULT UPDATE 27th October, 2017 . RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside

More information

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research Strong growth in core services October 19, 2015 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs494 Target Price Rs625

More information

KPR Mills Ltd 1QFY18 Result Update Target: Rs 944. Textile revenue impacted by slowdown due to GST, recovery from 2QFY18 onwards

KPR Mills Ltd 1QFY18 Result Update Target: Rs 944. Textile revenue impacted by slowdown due to GST, recovery from 2QFY18 onwards KPR Mills Ltd 1QFY18 Result Update Target: Rs 944 Previous Rating: Accumulate Current Rating: Accumulate Textile revenue impacted by slowdown due to GST, recovery from 2QFY18 onwards CMP (Rs) 806 Target

More information

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176 : price: EPS: Tepid volume growth continues 4QFY15 traded volumes in MCX showed a small improvement sequentially whereas declined yoy. FY15 traded Values are at a sever year low. We retain our cautious

More information

Q4 EARNINGS REPORT Welspun India 25 Apr 17

Q4 EARNINGS REPORT Welspun India 25 Apr 17 Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer

More information

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630 1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Bayer Cropscience (BYRCS IN)

Bayer Cropscience (BYRCS IN) (BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE

More information

LARGE CAP & 1,970 BSE

LARGE CAP & 1,970 BSE Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Misses estimates; Higher costs dims hope for earnings recovery February 13, 2017 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Rating Reduce Price Rs325 Target Price Rs320 Implied Upside 1.5%

More information

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart. Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Jan-17 Apr-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Jul-18 1QFY2019 Result Update Cons. Durable August 10, 2018 Blue Star Ltd Performance

More information

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research Growth led by Enterprise Retain BUY October 26, 20 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Hussain Kagzi hussainkagzi@plindia.com +91 22 66322242 Rating BUY Price Rs669 Target Price Rs780

More information

JK Lakshmi Cement. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research Expansions on schedule; lower costs to aid margins June 28, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price Rs385 Target

More information

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250

More information

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018 RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP

More information